TickerSpark Feed

BDX coverage

Every article, report, and earnings note where BDX appears.

Davion Healthcare Prices Nasdaq Direct Listing on Home Testing Push
IPODAVI

Davion Healthcare Prices Nasdaq Direct Listing on Home Testing Push

Davion Healthcare Plc is set to list on Nasdaq on 2026-10-22, with a price range not disclosed and a market cap of $252,750,000. The company is coming public as a direct listing, so there is no traditional underwritten IPO bookbuild or IPO proceeds. The bull case is a pre-revenue medtech story with multiple registered products and a consumer OTC model. The bear case is that the stock starts trading without the cushion of an IPO raise, while cash remains extremely thin and execution risk is high.

Oct 21, 20266 MIN
On-Demand Research

Want a deeper dive on BDX?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate BDX Report